{"id":"NCT02447991","sponsor":"Robert W. Baloh","briefTitle":"Rizatriptan for Episodic Dizziness in Vestibular Migraine","officialTitle":"A Phase II/III Trial on Rizatriptan for Vestibular Migraine","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2014-12","primaryCompletion":"2020-07-31","completion":"2020-07-31","firstPosted":"2015-05-19","resultsPosted":"2021-11-04","lastUpdate":"2021-11-04"},"enrollment":223,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Vestibular Migraine","Migrainous Vertigo"],"interventions":[{"type":"DRUG","name":"Rizatriptan","otherNames":["Maxalt"]},{"type":"DRUG","name":"Placebo","otherNames":["Sugar Pill"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Rizatriptan","type":"EXPERIMENTAL"}],"summary":"Suffering from dizzy spells and migraine headaches?\n\nVestibular Migraine (VM), a newly recognized type of migraine that causes bouts of dizziness.\n\nUniversity of California, Los Angeles (UCLA) and The Mayo Clinic is seeking people with VM to participate in a research study. The purpose of this study is to look at the natural history of VM and learn more about common symptoms. Investigators also want to learn the effects, both positive and negative, of the commonly used migraine drug, rizatriptan, when it is used for spells of dizziness in people with VM.\n\nPatients may be eligible to participate if:\n\n* Patients are between the ages of 18 \\& 65\n* Patients have a history of vestibular migraine\n* Patients are able to maintain a vestibular symptom diary\n\nThe study includes 3 visits with compensation. All participants must complete questionnaires on dizziness, headache symptoms, general health and well-being, mental health, and a questionnaire on patient's satisfaction with study medication.","primaryOutcome":{"measure":"Episodes With Vertigo Symptom Reduced From Moderate/Severe to None/Mild","timeFrame":"1 hour after taking study medication","effectByArm":[{"arm":"Placebo","deltaMin":50,"sd":null},{"arm":"Rizatriptan","deltaMin":73,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.33"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["40354049"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":45},"commonTop":["Sleepiness/drowsiness","Fatigue","Upset stomach, nausea, vomiting","Worsening of headache","Worsening of dizziness or gait"]}}